$MTNB

Matinas BioPharma Holdings, Inc.

NYSE · Healthcare · Pharmaceutical Preparations · Bedminster, NJ

MTNB chart

What traders are saying about $MTNB

Latest posts

Matinas BioPharma Holdings, Inc. news

Matinas BioPharma Holdings, Inc. key financials

USD2025202420232022
Revenue––$1.1M$3.2M
Net income-$10.3M-$24.3M-$22.9M-$21.0M
Diluted EPS$-2.00$-4.98$-5.28$-0.10
Total assets (year end)$7.2M$12.6M$25.1M$44.8M
Cash and equivalents (year end)$4.0M$7.3M$4.8M$6.8M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 10-Q10-Q
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 10-Q10-Q
  • 8-K8-K
  • 10-K10-K
  • 8-K8-K
  • 8-K8-K

About Matinas BioPharma Holdings, Inc.

Ticker
MTNB (NYSE)
Industry
Pharmaceutical Preparations
Headquarters
Bedminster, NJ
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
1582554

Frequently asked questions

What exchange is Matinas BioPharma Holdings, Inc. listed on?

Matinas BioPharma Holdings, Inc. trades on the NYSE under the ticker symbol MTNB.

What industry is Matinas BioPharma Holdings, Inc. in?

Matinas BioPharma Holdings, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is Matinas BioPharma Holdings, Inc. headquartered?

Matinas BioPharma Holdings, Inc.'s business address on file with the SEC is in Bedminster, NJ.

When does Matinas BioPharma Holdings, Inc.'s fiscal year end?

Matinas BioPharma Holdings, Inc.'s fiscal year ends on December 31.

How much revenue did Matinas BioPharma Holdings, Inc. report?

Matinas BioPharma Holdings, Inc. reported $1.1M in revenue for calendar year 2023, according to its SEC filings.